Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity

PURPOSE: To report on 2 cases of aggressive posterior retinopathy of prematurity (ROP) treated with intravitreal ranibizumab (Lucentis(®)) and laser photocoagulation. METHODS: Two premature females, born at 25 and 26 weeks’ gestation with a birth weight of 530 and 550 g, respectively, with aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mota, Ágata, Carneiro, Ângela, Breda, Jorge, Rosas, Vitor, Magalhães, Augusto, Silva, Renato, Falcão-Reis, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: April, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362187/
https://www.ncbi.nlm.nih.gov/pubmed/22649347
http://dx.doi.org/10.1159/000338623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362187/
https://www.ncbi.nlm.nih.gov/pubmed/22649347
http://dx.doi.org/10.1159/000338623

Ejemplares similares